Kumar Krishnaswamy

Kumar Krishnaswamy is an experienced scientific director at AbbVie since May 2023, with a robust background in cellular immunology. Prior roles include head of translational medicine at Galderma and principal scientist leading a global research team, focusing on target identification and validation for immune-mediated diseases in dermatology and respiratory therapeutic areas. At AstraZeneca, Kumar held the position of senior research bioscientist, specializing in preclinical research and the establishment of disease-relevant models. A postdoctoral associate at Yale University School of Medicine, Kumar investigated factors regulating dendritic cell migration and its effects on immune responses. Educational credentials include a Ph.D. in immunology from Medizinische Hochschule Hannover, alongside a master's degree in biotechnology and a bachelor's degree in microbiology.